tirzepatide and bladder issues What are the management options for urinary incontinence after stopping Mounjaro (tirzepatide)? Shifting the Scales: Tirzepatide's Breakthrough

Noom encourages creating a bedtime routine that supports better rest, such as limiting screen time before bed, maintaining a consistent sleep schedule, and managing stress in the evenings

Remarkably, one in three individuals achieved a 25% reduction in body weight, equating to a loss of 58 pounds Semaglutide (Wegovy): Wegovy users have experienced significant weight loss as well, with adults averaging a 15% reduction in body weight and a 16.1% decrease in BMI among children aged 12 and older Clinical trial comparisons: SURMOUNT-1 (Zepbound): Participants using the highest dose of Zepbound (15 mg) experienced an average weight loss of 21% after 72 weeks SURMOUNT-2 (Zepbound): In adults with type 2 diabetes, the same high dose led to a 12% weight loss after 72 weeks Wegovy trials: Comparable trials for Wegovy have shown an average weight loss of 15% from the starting weight in adults who are overweight or have obesity Cost considerations: The price of these medications is a factor to consider

Ethics approval and consent to participate Ethics approval was granted from Hampstead Research Ethics Committee (REC) (reference 22/LO/0506)

The middle of the thigh, from mid-front to mid-side, on the outside part of the thigh, is a safe site